Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-12-01
著者
-
Edom Richard
Bioanalysis/dmpk Johnson And Johnson Pharmaceutical Research And Development
-
Edom Richard
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
Gallagher Joseph
Bioanalysis/dmpk Johnson And Johnson Pharmaceutical Research And Development
-
Weng Naidong
Bioanalysis/dmpk Johnson And Johnson Pharmaceutical Research And Development
-
Weng Naidong
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
Jian Wenying
Bioanalysis/dmpk Johnson And Johnson Pharmaceutical Research And Development
-
Jian Wenying
Bioanalysis/dmpk Johnson & Johnson Pharmaceutical Research And Development
-
XU Yaodong
Bioanalysis/DMPK, Johnson and Johnson Pharmaceutical Research and Development
-
Xu Yaodong
Bioanalysis/dmpk Johnson And Johnson Pharmaceutical Research And Development
関連論文
- Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma
- Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites